Skip to main content
logo
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,794.40
+11.20 (0.63%)
At close: Mar 17, 2026

NSE:SUNPHARMA Revenue

Sun Pharmaceutical Industries had revenue of 155.21B INR in the quarter ending December 31, 2025, with 13.49% growth. This brings the company's revenue in the last twelve months to 568.09B, up 10.09% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.

Revenue (ttm)
568.09B
Revenue Growth
+10.09%
P/S Ratio
7.58
Revenue / Employee
13.21M
Employees
43,000
Market Cap
4.31T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aurobindo Pharma331.82B
Cipla279.67B
Zydus Lifesciences260.89B
Glenmark Pharmaceuticals165.10B
Alkem Laboratories142.53B
Mankind Pharma139.14B
Divi's Laboratories103.14B
Ipca Laboratories95.06B
Revenue Rankings

Sun Pharmaceutical Industries News

More News